Acute Social Anxiety Disorder Market Set to Grow Rapidly Through 2035 – BIS Research

What Is the Market Outlook? 

The acute social anxiety disorder market is transitioning from early growth to maturity. Expanded diagnostic capabilities, including digital tools and VR, are augmenting access and early intervention. Stigma and cost barriers persist in low-income regions, but policy-level focus on mental health is fostering improvements in personalized treatment and care integration. 

How Fast Is the Market Growing? 

While specific figures for market size and CAGR weren’t disclosed in publicly available summaries, BIS forecasts strong growth supported by rising demand, treatment innovation, and digital intervention uptake. 

How Will This Report Help You? 

• Planning to Enter the Market? 

Understand region-specific dynamics across North America, Europe, Asia‑Pacific, and Rest‑of‑World, including unmet needs and digital healthcare adoption. 

• Analyzing the Competitive Landscape? 

Access benchmarking on dominant players like Vistagen, Neuphoria Therapeutics, and PureTech Health—covering pipelines, partnerships, and diagnostics. 

• Seeking R&D Insights? 

Explore cutting-edge treatments: fasedienol nasal spray (Phase 3), VR-based therapies, smartphone-based monitoring, and other AI-supported diagnostics. 

• Interested in Regional Market Trends? 

Obtain detailed segmentation, including U.S., EU5, Japan, China, India, and RoW forecasts along with regional regulatory outlines. 

Explore the Full TOC and Download Report Sample    

What Technologies Are Transforming the Market? 

• Digital diagnostics & MRV: smartphone‑based video and facial analysis tools for real‑time anxiety detection. 
• Virtual Reality (VR): self‑guided VR platforms for therapeutic use in social anxiety and public speaking. 
• Novel pharmacotherapies: 
• Fasedienol (PH94B/Aloradine): intranasal pherine in Phase 3 development by Vistagen/VistaGen. 
• BNC‑210 (Soclenicant): α7‑nAChR NAM in Phase 3 for social anxiety  

What’s Driving Demand and What Are the Barriers? 

Drivers: 

• Rising prevalence and societal awareness of anxiety disorders. 
• Innovation in diagnostics and treatments (digital and pharmacological). 
• Expanded access through telemedicine, apps, and VR. 

Restraints: 

• Persistent stigma in developing regions. 
• High cost and uneven access to advanced therapies. 
• Treatment variability effectiveness and lack of regulator-approved drugs (apart from progressive pipeline assets)  

Opportunities: 

• Deployment of VR and AI tools in underserved markets. 
• Expansion of telepsychiatry and digital mental health solutions. 
• Potential for regulatory approval of fasedienol and BNC‑210 to reshape therapeutic landscape. 

Who Are the Key Players in the Market? 

• Vistagen 
• Neuphoria Therapeutics Inc. 
• PureTech Health 
• Other Companies 

Strategic Moves Shaping the Future: 

• Pipeline therapies like fasedienol and BNC‑210 could receive approval during 2025–2030, transforming treatment options. 
• Digital mental health innovations—VR, smartphone-analytics—are gaining traction, providing scalable, cost-effective alternatives. 
• Collaborations between pharma and digital health firms are expected to intensify, aiming to integrate diagnostic tools with therapeutics. 

Download the complete TOC now! 

Case Study: Vistagen’s Fasedienol (PH94B/Aloradine) 

• Intranasal “pherine” in Phase 3 for acute social anxiety. 
• Enrolled first subject in repeat-dose study in January 2025. 
• Represents a fast-acting alternative to SSRIs and benzodiazepines, with potential to fill an unmet acute-episode treatment gap. 

Schedule a Call with Industry Experts 

Related Reports from BIS Research 

Global Burns Market 

Alcohol Use Disorder Market 

Rare Disease Genetic Testing Market 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing  

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686  

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch